Victoria-Jungfrau Collection AG has been acquired by AEVIS Holding SA
The shareholders of Victoria Jungfrau Collection AG, (VJC) the Swiss group of luxury hotels, received a public takeover offer from AEVIS Holding SA (AEVIS), a Swiss investment group focusing on the healthcare sector, acquiring a majority shareholding for US$69.5 million.
The Victoria-Jungfrau Collection AG is a small but exclusive hotel group with a unique portfolio of luxury five-star hotels of long standing. Other hotels of the group include The Victoria-Jungfrau Grand Hotel & Spa in Interlaken, the Palace Luzern on the shores of Lake Lucerne, the Eden au Lac in Zurich and the renowned Bellevue Palace in Bern.
AEVIS invests in the healthcare, life sciences, services and lifestyle sectors. The firm wishes to progressively develop new sectors of activity, amongst others in the sector of outpatient surgical centers, radiology and dental medicine and hotel or hotel related activities.
Oaklins' team in Switzerland was mandated by the board of VJC to assist in the assessment of the bids from a financial perspective. It was imperative to focus on the interests of the company and the shareholders and to achieve a fair price, while taking into consideration the strategic plans for the target of each bidder. The competitive situation of two bidders resulted in a stepwise increase of the price.
Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more